The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point of Care Diagnostics (POCD) Market Research Report 2025

Global Point of Care Diagnostics (POCD) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1714634

No of Pages : 109

Ask Your Query
Synopsis
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global Point of Care Diagnostics (POCD) market was valued at US$ 25670 million in 2023 and is anticipated to reach US$ 34550 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Point of Care Diagnostics (POCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Diagnostics (POCD).
Report Scope
The Point of Care Diagnostics (POCD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point of Care Diagnostics (POCD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Diagnostics (POCD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Segment by Application
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care Diagnostics (POCD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2019-2030)
2.2 Point of Care Diagnostics (POCD) Growth Trends by Region
2.2.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point of Care Diagnostics (POCD) Historic Market Size by Region (2019-2024)
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2025-2030)
2.3 Point of Care Diagnostics (POCD) Market Dynamics
2.3.1 Point of Care Diagnostics (POCD) Industry Trends
2.3.2 Point of Care Diagnostics (POCD) Market Drivers
2.3.3 Point of Care Diagnostics (POCD) Market Challenges
2.3.4 Point of Care Diagnostics (POCD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2019-2024)
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2019-2024)
3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2023
3.5 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Diagnostics (POCD) Breakdown Data by Type
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2019-2024)
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2025-2030)
5 Point of Care Diagnostics (POCD) Breakdown Data by Application
5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2019-2024)
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size (2019-2030)
6.2 North America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
6.4 North America Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size (2019-2030)
7.2 Europe Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2019-2030)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2019-2030)
9.2 Latin America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2019-2030)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.1.5 Alere Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.5.5 Siemens Healthcare Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.7.5 QIAGEN Recent Development
11.8 Bayer Healthcare
11.8.1 Bayer Healthcare Company Detail
11.8.2 Bayer Healthcare Business Overview
11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.8.5 Bayer Healthcare Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Detail
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.9.5 Beckman Coulter Recent Development
11.10 Nipro Diagnostics
11.10.1 Nipro Diagnostics Company Detail
11.10.2 Nipro Diagnostics Business Overview
11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.10.5 Nipro Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Nova Biomedical
11.12.1 Nova Biomedical Company Detail
11.12.2 Nova Biomedical Business Overview
11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.12.5 Nova Biomedical Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Detail
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.13.5 BioMerieux Recent Development
11.14 Quidel
11.14.1 Quidel Company Detail
11.14.2 Quidel Business Overview
11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.14.5 Quidel Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Detail
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.15.5 Helena Laboratories Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Detail
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.16.5 OraSure Technologies Recent Development
11.17 Accriva
11.17.1 Accriva Company Detail
11.17.2 Accriva Business Overview
11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.17.5 Accriva Recent Development
11.18 Abaxis
11.18.1 Abaxis Company Detail
11.18.2 Abaxis Business Overview
11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.18.5 Abaxis Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Detail
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
11.19.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.19.5 Chembio Diagnostics Recent Development
11.20 Trinity Biotech
11.20.1 Trinity Biotech Company Detail
11.20.2 Trinity Biotech Business Overview
11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.20.5 Trinity Biotech Recent Development
11.21 Instrumentation Laboratory
11.21.1 Instrumentation Laboratory Company Detail
11.21.2 Instrumentation Laboratory Business Overview
11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.21.5 Instrumentation Laboratory Recent Development
11.22 Sekisui Diagnostics
11.22.1 Sekisui Diagnostics Company Detail
11.22.2 Sekisui Diagnostics Business Overview
11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.22.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock